An increasing number of studies have demonstrated that NF-κB activation, accompanied by secretion of pro-inflammatory cytokines, is associated with neuronal degeneration in the brains of AD patients (Boissière et al., 1997; He et al., 2011). Here, NFKB1 is linked to Alzheimer disease.